Top Stories

Shares of thyssenKrupp AG (TYEKF.PK) were gaining around 2 percent in the morning trading in Germany after the steel giant Thursday said it expects clearly positive net income and significantly higher adjusted EBIT, a key earnings metric, in fiscal 2018....

Merval, the main index of the Buenos Aires Stock Exchange, rose 0.22% to close at 27,327.38 points Wednesday, giving up earlier gains amid a volatile session. Banco Macro's shares rose 0.57% after its board of directors accepted the leave request presented...


As family and friends prepare to get together to celebrate Thanksgiving, the results of a Quinnipiac University national poll found that most voters are hoping to avoid discussing politics. Sixty-three percent of voters said they are hoping to avoid...


European markets likely to open subdued following Asian peers, amid indication of possible hike in U.S. interest rates in the near term. Wall Street ended flat overnight and is closed today for Thanksgiving Day holiday.


Kendall Jenner is the world's highest-earning model, a title monopolized by super model Gisele Bundchen for the last 15 years. The 22-year old beauty steals the top spot in Forbes highest paid models' list, raking in a mammoth $22 million in the 12...

sharehigher3-111617.jpg European stocks rebounded after recent losses on Thursday as oil held steady, the dollar bounced back from four-week lows and investors kept an eye on U.S. tax reform developments. The day's economic reports proved to be a mixed bag, with Eurozone...
Carney-BoE-111617.jpg The Bank of England stands ready to support the UK economy during the Brexit transition period irrespective of whether the government strikes a deal with the European Union, the bank's chief Mark Carney said Thursday. "We will do whatever we can to...
wallstreet-111617.jpg The Futures market is gaining traction and Wall Street might be opening higher on Thursday. Shrugging of a week phase, Asian and European markets are back on a positive note. Asian shares closed broadly higher, while European shares are climbing. The economic scenario is rich with several announcements and a slew of fed speeches. Labor Department's Jobless claims is expected to decline, while Fed'
Roymoore-111617.jpg An opinion poll conducted after five women accused Roy Moore of making sexual advances towards them shows a dramatic turn against him in the run-up to the Alabama Senate Special election. According to the results of a poll from the National Republican...
Trump-Roymoore-112217.jpg President Donald Trump's remarks at a White House press conference appear to be giving the benefit of doubt to Republican Alabama Senate candidate Roy Moore, who is accused of preying on teenagers. Talking to reporters Tuesday on the South Lawn before...
LisaMurkowski-112217.jpg Senator Lisa Murkowski, R-Alaska, has expressed support for repealing Obamacare's individual mandate, a key provision Senate Republicans are hoping to use to offset the cost of their tax reform bill. The Congressional Budget Office estimates repealing...
Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
The mood in the French stock market is quite cautious Thursday morning, despite some fairly upbeat economic data. The largely cautious mood across the globe on expectations of a rate hike in the U.S. in December appears to be prompting investors to refrain from making significant moves. The benchmark...
Apple Inc. has recently acquired Canada-based startup Vrvana, maker of the Totem augmented reality headset, TechCrunch reported. Both the companies reportedly declined to confirm news about the deal, which is reportedly worth $30 million.
Today's Daily Dose brings you news about FDA approval of the first 2-drug regimen for HIV; share repurchase by SunLink Health; promising early observations from DelMar's phase II trial of VAL-083 in glioblastoma; Starpharma's progress in Bacterial Vaginosis trial and Ardelyx's pipeline update. More
Shares of Medicrea Group climbed around 31 percent in the morning trading in Paris after the French medical devices company announced Wednesday that it has received Food and Drug Administration or FDA clearance for its IB3D range of 3D-printed Titanium... More
Zimbabwe's leader Robert Mugabe has vowed to stay in power for several weeks, despite intensifying pressure on him to stand down, according to reports. In a live TV address, Mr Mugabe said he would preside over the ruling party's congress in December. The...
Divergent3d-112217.jpg Automotive startup Divergent 3D said that a Chinese-led investment syndicate has agreed to commit up to $107 million in financing through a new investment round. Hong Kong-based investment holding company, O Luxe Holdings Limited, led the investment group, which includes Horizons Ventures, Shanghai Alliance Investment Limited and Altran Technologies.
Follow RTT
Economic Calendar
11/23/17 5:0M3 Money Supply (Y-o-Y)OCT Bulgaria
11/23/17 5:0Unemployment RateOCT Iceland
11/23/17 4:30Index of Services (3M-o-3M)SEP UK
11/23/17 4:30GDP (Q-o-Q)Q3 UK
11/23/17 4:30GDP (Y-o-Y)Q3 UK
11/23/17 4:30Total Business Investment (Q-o-Q)Q3 P UK
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
01/10/18LLYAbemaciclib (NDA)FDA decision on Abemaciclib for the treatment of advanced breast cancer
Complete FDA Calendar